Cellectar Biosciences Inc (NASDAQ: CLRB) is 29.00% higher on its value in year-to-date trading and has touched a low of $0.22 and a high of $4.17 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLRB stock was last observed hovering at around $0.38 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.39, the stock is 23.82% and 32.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.55 million and changing 2.28% at the moment leaves the stock -75.42% off its SMA200. CLRB registered -88.92% loss for a year compared to 6-month loss of -81.46%. The firm has a 50-day simple moving average (SMA 50) of $0.291 and a 200-day simple moving average (SMA200) of $1.5696.
The stock witnessed a 22.80% gain in the last 1 month and extending the period to 3 months gives it a 48.35%, and is 21.83% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.73% over the week and 9.45% over the month.
Cellectar Biosciences Inc (CLRB) has around 11 employees, a market worth around $17.78M and $0.00M in sales. Distance from 52-week low is 72.19% and -90.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-277.14%).
The EPS is expected to grow by 47.54% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
33.0 institutions hold shares in Cellectar Biosciences Inc (CLRB), with institutional investors hold 11.18% of the company’s shares. The shares outstanding are 46.08M, and float is at 45.31M with Short Float at 4.34%. Institutions hold 11.00% of the Float.
Cellectar Biosciences Inc (CLRB) Insider Activity
The most recent transaction is an insider purchase by Longcor Jarrod, the company’s Chief Operating Officer. SEC filings show that Longcor Jarrod bought 30,000 shares of the company’s common stock on Jan 10 ’25 at a price of $0.28 per share for a total of $8400.0. Following the purchase, the insider now owns 83141.0 shares.
